BioSystem Development is a privately held company that develops and manufactures the AssayMAP Microchromatography system to meet the analytical demands of the life span sciences market. Agilent announced the signing of an acquisition agreement on Dec. 1. Financial information on the transaction were not disclosed. Related StoriesUnique, small proteins cage developed to deliver chemotherapy chemicals directly to malignancy cellsUnderstanding how schizophrenia impacts workings of the brainDiscovery could offer clues to how some infections control expression of genetic materialAs lifestyle science discovery and advancement continues to go toward a better knowledge of biological responses to disease, and has an increased focus on protein-structured therapeutics by pharmaceutical companies, the need for automated, quality protein sample preparation and analysis has become important.Johnson & Johnson and its McNeil-PPC Inc. Subsidiary should pay Samantha Reckis and her parents a total of $109 million, including interest, a Plymouth Superior Court jury decided on Wednesday. Samantha was 7 when she was given Motrin brand ibuprofen, family attorney Brad Henry said. She experienced a rare side effect referred to as toxic epidermal necrolysis and dropped 90 % of her skin and was blinded, he stated. She suffered brain harm that ‘thankfully’ involved just short-term memory reduction, he said, and surgeons had to drill through her skull to relieve some pressure.